THE ACME LABORATORIES LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.5 BDT | -1.89% |
|
-3.98% | -20.59% |
| Sales 2022 | 23.86B 217M 17.37B | Sales 2023 | 26.95B 245M 19.61B | Capitalization | 18.2B 165M 13.25B |
|---|---|---|---|---|---|
| Net income 2022 | 2.11B 19.2M 1.54B | Net income 2023 | 2.3B 20.95M 1.68B | EV / Sales 2022 | 1.4 x |
| Net Debt 2022 | 14.69B 134M 10.7B | Net Debt 2023 | 19.32B 176M 14.07B | EV / Sales 2023 | 1.39 x |
| P/E ratio 2022 |
8.91
x | P/E ratio 2023 |
7.9
x | Employees | 8,816 |
| Yield 2022 |
3.37% | Yield 2023 |
3.84% | Free-Float | 52.64% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.89% | ||
| 1 week | -3.98% | ||
| Current month | -6.64% | ||
| 1 month | -7.41% | ||
| 3 months | -14.34% | ||
| 6 months | -20.59% | ||
| Current year | -20.59% |
1 week
66.80
70.70
1 month
66.8073.70
Current year
66.8085.00
1 year
66.8093.50
3 years
66.80117.70
5 years
54.20117.70
10 years
54.20124.80
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | 17/03/75 | |
| Director of Finance/CFO | - | - | |
Md. Hossain
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Das Prashad
BRD | Director/Board Member | - | 09/12/20 |
| Director/Board Member | 59 | - | |
| Chief Executive Officer | 80 | 17/03/75 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/04/24 | 67.5 | -1.89% | 137,229 |
| 24/04/24 | 68.8 | -0.15% | 81,523 |
| 23/04/24 | 68.9 | -0.29% | 83,201 |
| 22/04/24 | 69.1 | -1.00% | 278,500 |
| 21/04/24 | 69.8 | -0.71% | 67,269 |
End-of-day quote Dhaka S.E., April 24, 2024
More quotes
The ACME Laboratories Limited is a Bangladesh-based company, which is engaged in manufacturing, marketing, and distribution of pharmaceuticals formulation products. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products and sachet products. It also offers veterinary drugs comprising dosages form like bolus, liquid, injection, water-soluble powder, premix, and herbal drugs comprising dosages form like liquid, capsule, tablet and cream and ointment. The products of the Company are sold in domestic and international markets respectively. Its factory is situated at Dhulivita, Dhamrai, Dhaka, Bangladesh. It produces approximately 800 products in different dosage forms.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -20.59% | 130M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- ACMELAB Stock
